NOVAVAX INC's ticker is and the CUSIP is 670002AB0. A total of 22 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $16,180,383 | -66.1% | 16,288,000 | -66.4% | 0.49% | -73.9% |
Q3 2022 | $47,682,000 | -44.1% | 48,538,000 | -42.9% | 1.89% | -45.4% |
Q2 2022 | $85,374,000 | -0.1% | 85,038,000 | +6.2% | 3.46% | +17.2% |
Q1 2022 | $85,465,000 | -15.6% | 80,038,000 | +8.4% | 2.95% | -31.6% |
Q4 2021 | $101,221,000 | -16.2% | 73,811,000 | +6.0% | 4.31% | -29.9% |
Q3 2021 | $120,846,000 | +3.1% | 69,636,000 | +6.1% | 6.15% | +0.2% |
Q2 2021 | $117,228,000 | +8.1% | 65,636,000 | 0.0% | 6.14% | +27.1% |
Q1 2021 | $108,450,000 | +78.4% | 65,636,000 | +36.9% | 4.83% | +116.3% |
Q4 2020 | $60,788,000 | +5.8% | 47,936,000 | 0.0% | 2.23% | +12.8% |
Q3 2020 | $57,429,000 | +173.0% | 47,936,000 | +118.5% | 1.98% | +95.5% |
Q2 2020 | $21,037,000 | +176.3% | 21,936,000 | +122.7% | 1.01% | +88.5% |
Q1 2020 | $7,613,000 | +60.9% | 9,850,000 | -16.9% | 0.54% | +212.2% |
Q4 2019 | $4,732,000 | -6.1% | 11,850,000 | 0.0% | 0.17% | +4.9% |
Q3 2019 | $5,039,000 | +5.1% | 11,850,000 | 0.0% | 0.16% | +16.3% |
Q2 2019 | $4,795,000 | +49.9% | 11,850,000 | +37.8% | 0.14% | -18.0% |
Q1 2019 | $3,199,000 | – | 8,600,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Graham Capital Management, L.P. | 65,636,000 | $117,228,000 | 6.14% |
WHITEBOX ADVISORS LLC | 34,014,000 | $60,630,000 | 1.23% |
Saltoro Capital, LP | 1,500,000 | $2,689,000 | 1.09% |
DeepCurrents Investment Group LLC | 19,500,000 | $35,011,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 25,000,000 | $44,647,000 | 0.79% |
CSS LLC/IL | 9,250,000 | $16,583,000 | 0.69% |
WOLVERINE ASSET MANAGEMENT LLC | 48,772,000 | $87,240,000 | 0.66% |
SSI INVESTMENT MANAGEMENT LLC | 2,914,000 | $5,198,000 | 0.34% |
LINDEN ADVISORS LP | 27,403,000 | $48,980,000 | 0.26% |
PFM Health Sciences, LP | 4,250,000 | $7,612,000 | 0.24% |